Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
0.2510
-0.1290
-33.95%
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Ampio Pharm (AMPE)
Add to/Remove from a Portfolio
Add to Watchlist
- Volume: 1,812
- Bid/Ask: 0.0000 / 0.0000
- Day's Range: 0.2200 - 0.2510
Type:
Equity
Market:
United States
Ampio Pharm
0.2510
-0.1290
-33.95%
- Discussions
- Recent Sentiments
- User Rankings
AMPE User Rankings
Bellow, users are ranked according to the performance of their sentiments for the Ampio Pharm stock.
| Rank | Username | Total | Closed | Winning | Win % | Chg. % |
|---|---|---|---|---|---|---|
| 1 | direttore limi | 1 | 1 | 1 | 100 | +95.06% |
| 2 | Charlie Oxendine | 1 | 1 | 1 | 100 | +80% |
| 3 | Марат Азмуханов | 1 | 1 | 1 | 100 | +47.16% |
| 4 | Ivica Maurovic | 1 | 1 | 1 | 100 | +42.86% |
| 5 | Marco Bernasconi | 1 | 1 | 1 | 100 | +42.18% |
| 6 | Char Potes | 1 | 1 | 1 | 100 | +40.42% |
| 7 | Ahmed Tabsoba | 1 | 1 | 1 | 100 | +39.69% |
| 8 | Dan Nguyen | 1 | 1 | 1 | 100 | +30.49% |
| 9 | Diana Williams | 1 | 1 | 1 | 100 | +26.71% |
| 10 | Edu calvo | 1 | 1 | 1 | 100 | +25% |
| 11 | Valdemar Leal | 2 | 2 | 1 | 50 | +19.15% |
| 12 | Jonathan Nicholson Soro | 1 | 1 | 1 | 100 | +17.65% |
| 13 | Hagman Muchenje | 1 | 1 | 1 | 100 | +15.5% |
| 14 | Abdulrhmman Talal | 1 | 1 | 1 | 100 | +13.56% |
| 15 | jon armendariz | 1 | 1 | 1 | 100 | +13.32% |
| 16 | jm landaluce | 3 | 3 | 3 | 100 | +11.16% |
| 17 | Jake Anderson | 1 | 1 | 1 | 100 | +10.69% |
| 18 | Hermann Albrecht | 2 | 2 | 2 | 100 | +9.11% |
| 19 | Robbert Kuipers | 1 | 1 | 1 | 100 | +8.11% |
| 20 | Luca Percuoco | 1 | 1 | 1 | 100 | +6.03% |
| 21 | Angelo Elvi | 1 | 1 | 1 | 100 | +5.51% |
| 22 | walter lopez | 1 | 1 | 1 | 100 | +4.9% |
| 23 | Martina frias terres | 1 | 1 | 1 | 100 | +4.35% |
| 24 | дмитрий лысенко | 1 | 1 | 1 | 100 | +3.27% |
| 25 | andy mcvarish | 1 | 1 | 1 | 100 | +3.21% |
| 26 | shazad ali | 1 | 1 | 1 | 100 | +3.07% |
| 27 | plonen plonen | 1 | 1 | 1 | 100 | +2.76% |
| 28 | David Prieto Cabado | 1 | 1 | 1 | 100 | +2.44% |
| 29 | Danieldank Santos | 1 | 1 | 1 | 100 | +2.21% |
| 30 | Владимир Бобачев | 1 | 1 | 1 | 100 | +1.44% |
| 31 | Асхат Игам | 1 | 1 | 1 | 100 | +0.67% |
| 32 | Jorge Mera Santiago | 1 | 1 | 1 | 100 | +0.66% |
| 33 | Nicholas Maney | 1 | 1 | 0 | 0 | -0.83% |
| 34 | Arnaldo Pastore | 1 | 1 | 0 | 0 | -1.35% |
| 35 | Jay William | 1 | 1 | 0 | 0 | -1.44% |
| 36 | Christopher Muñoz | 1 | 1 | 0 | 0 | -2.44% |
| 37 | Mattia Antonini | 1 | 0 | 0 | 0 | -4.11% |
| 38 | FJavier Jiménez | 1 | 1 | 0 | 0 | -4.59% |
| 39 | Ленчик Мерк | 1 | 1 | 0 | 0 | -5.03% |
| 40 | leonardo bonora | 1 | 1 | 0 | 0 | -6.11% |
| 41 | Stephane Pare | 1 | 1 | 0 | 0 | -7.41% |
| 42 | Phill San | 1 | 1 | 0 | 0 | -7.55% |
| 43 | tawfek hasan | 1 | 1 | 0 | 0 | -7.95% |
| 44 | Armando cuko | 1 | 1 | 0 | 0 | -9.91% |
| 45 | Ezzat Mahran | 1 | 1 | 0 | 0 | -10.25% |
| 46 | Rogelio Jaralba | 1 | 1 | 0 | 0 | -11.76% |
| 47 | özgür kaya | 1 | 1 | 0 | 0 | -12.18% |
| 48 | Kallol Das | 1 | 1 | 0 | 0 | -12.63% |
| 49 | Josh Rowe | 1 | 1 | 0 | 0 | -13.56% |
| 50 | Luca Borgna | 4 | 4 | 2 | 50 | -14.91% |
Write your thoughts about Ampio Pharm
Are you sure you want to delete this chart?
Delete Cancel
Replace the attached chart with a new chart ?
Replace Cancel
Comment Guidelines
Ken McColl
Jul 28, 2020 17:48
28July. Purchased 10k shares yesterday. Down 7% today
1
0
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review